Sponsor:
Massachusetts General Hospital
Code:
NCT07439042
Conditions
Anxiety
Autism Spectrum Disorder
Eligibility Criteria
Sex: All
Age: 7 - 17
Healthy Volunteers: Not accepted
Interventions
buspirone
Placebo
Brief summary:
Conditions
Anxiety
Autism Spectrum Disorder
Study ID
NCT07439042
Start date
Sep, 2026
Status verified date
Sep, 2026
Completion date
Jun, 2029
Anticipated
Primary completion date
Feb, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 7 - 17
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Buspirone
placebo comparator: Placebo
Interventions
buspirone
Placebo
Primary outcome measure
Central contacts
Locations
Lurie Center
Recruiting
Lexington, Massachusetts, United States, 02421
Sponsor
Massachusetts General Hospital
Last update posted
Sep 17, 2026
Last verified
Sep, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-18. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-09-17.